Monday, July 4, 2022
wellness India Expo
Home Tags Dr Soumya Swaminathan

Tag: Dr Soumya Swaminathan

BioAsia 2022: India’s biotech sector stakeholders discuss learnings from pandemic

Normally a vaccine development process takes 6-8 years for research and trials, but path-breaking work has been done in India

Two years into the pandemic: BioAsia 2022 announces a stellar speaker...

The panel discussion will feature pioneers, innovators and leaders, the likes of Dr. Soumya Swaminathan (Chief Scientist, World Health Organization); Dr. Peter Piot (Director, EU Chief Scientific Advisor Epidemics), and Mr. Amitabh Kant (CEO, NITI Aayog) among others

5th Global forum on TB vaccines: Experts call for global funding...

Globally, there are 12 Tuberculosis vaccines in various stages of clinical trials, with many more candidates and concepts in earlier stages of development.....................

India’s Dr Soumya Swaminathan joins WHO as its second-in-command

The Secretary, DHR and DG of the ICMR, Dr Soumya Swaminathan has got a fresh assignment and this time it is the world's top health policy body, the World Health Organization............

India signs vaccine development treaty with IVI, South Korea

The Indian Council of Medical Research (ICMR) and the Department of Health and Family Welfare of health ministry have signed an agreement with the International Vaccine Institute to support vaccine development in India..........

Exclusive: Apex committee on clinical trials takes steps to streamline regulations

The issues related to streamlining of approvals to clinical trials were discussed and appropriate modifications were given green signal by the top health regulatory officials at their 34th apex committee meeting held recently at Delhi.........

PFI releases monograph detailing its achievements

The Population Foundation of India in last 47 years, has tried to change the policy environment through evidence based advocacy using a multi-sectoral approach...........

India’s quest to become a global biotech hub by 2025!

The BioVoice News takes you through the opinions of top policymakers on the preparations to transform Indian biotech industry into a giant hub in next crucial eight years..........

India develops national action plan to combat antimicrobial resistance

Antimicrobial resistance is a serious threat to global public health that requires action across all government sectors........

Hilleman Lab partners with NICED, ICMR to develop Shigella vaccine

The Hilleman Laboratories on March 29, 2017 signed a memorandum of understanding (MoU) with NICED, ICMR to develop an indigenous Shigella vaccine.....